Research

People with epilepsy more likely to die early

People with epilepsy are two to three times more likely to die prematurely than the rest of the population, research suggests

Patients aren’t disclosing their symptoms

Patients do not fully disclose symptoms during many consultations in UK primary care, new research reveals

PDE5 inhibitors are linked to hearing loss

PDE5 inhibitors, such as sildenafil, are associated with a “small but significantly increased risk” of sudden hearing loss

Paracetamol as effective as opioids, research finds

Non-opioid analgesics improved pain-related function over 12 months as much as opioids in back or osteoarthritic pain

Oral pain, children and pharmacy

Oral pain is the commonest reason why parents visit a pharmacy for pain relief for children, new research shows

Inhaled corticosteroids linked to COPD fractures

Long-term use of high dose inhaled corticosteroids is associated with a “modest” increased risk of fractures in COPD patients

Asthma drugs linked to fertility problems?

Short-acting beta-agonists (SABAs) may reduce fertility, according to the Screening for Pregnancy Endpoints study

Is migraine a risk factor for CVD?

Researchers have linked migraine to most CV diseases – and there is a strong stroke connection as well

Consumers don’t appreciate risks with OTC medicines

Patients believe non-prescription medicines are too weak to cause any real harm and can overdose, US research finds

One cigarette a day is one too many

Smoking just one cigarette a day is associated with at least half the risk of developing CHD or a stroke as smoking 20 per day

Benefits of smoking cessation drugs decline over time

The proportion of smokers who benefit from smoking cessation medications declines during the first year of treatment

Eyelid cancer on rise

Squamous cell carcinoma (SCC) affecting the eyelids is becoming commoner in England, according to new research

New research highlights potential analgesic risks on health outcomes

Analgesics for neuropathic pain and opioids may increase the risk of obesity and hypertension, according to new research

Cardiovascular risk rises with COPD treatments

A large increase in CVD incidence takes place within 30 days of starting certain COPD therapies, research finds

Probiotics alleviate childhood eczema

Probiotics can reduce the severity of atopic dermatitis and cut topical steroid use, according to a new study

Hypoglycaemia risk ranked

Sulfonylureas are associated with a higher likelihood of serious hypoglycaemia than metformin or thiazolidinediones

Study highlights codeine dependence – a problem for pharmacy?

Pharmacies are a common source of codeine for dependent people but only one in 50 users seeks a pharmacist’s support

Statins cut CV mortality

Pravastatin reduces long-term cardiovascular mortality by more a quarter, even in men with markedly raised LDL-C levels

Pharmacists could inject contraceptives

Community pharmacists could inject subcutaneous contraceptives but have concerns, research finds

Promising results for Bydureon

AZ's Bydureon does not increase the incidence of major CV events in patients with type 2 diabetes, research suggests

Previous 1 2 3 4 5 6 7 Next

Latest

MHRA recalls heart and blood pressure medication

The MHRA has recalled three batches of blood pressure and heart medication Irbesartan due to contamination fears

Pharmacy must reflect to prevent another Gosport, say bodies

Pharmacy bodies have collaborated on a learning resource on the events at Gosport, which saw at least 450 patients die

Views

Where next for the NHS Long-Term Plan?

By Royal Pharmaceutical Society England board chair Sandra Gidley As the dust settles from the publication of the long-...

Popular

UK drug shortages hit WBA sales

Boots UK parent company Walgreens Boots Alliance has launched a massive savings drive following disappointing resul...

Scenario: Travelling with CDs

Parveen is giving Graeme Alton his methadone instalments for the weekend. He tells her he is planning a holiday in Egypt...

Cannabis prescription changes kick in

The Government’s reclassification of cannabis-based products for medicinal use came into force on Thursday Novembe...



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.